GV (Google Ventures)

Activity from announced rounds

All recorded activity

GV invests in technology and life-science companies, including AI applications, developer tools, cybersecurity, computing infrastructure and healthcare.

Its AI interests span the stack: new computing systems and inference infrastructure, tools for developers, software for professional workflows and applications in drug discovery and patient care. This gives both infrastructure founders and application builders a route to a specialist investment team.

GV developed the design sprint, a five-day process that takes a business question through problem definition, prototyping and customer testing. Its published sprint materials help teams test demand and product decisions before committing to a full launch.

Sources
Rounds participated in
41
Confirmed lead rounds
2
32 roles undisclosed
New companies
39
First participation on record · 2 follow-on
Funding in participating rounds
$8.9B
41 disclosed · full round size, not this investor’s share

By stage

Series C+13
Series B11
Series A9
Undisclosed4
Seed3
1 more
Growth1

By primary sector

AI10
Biotech9
Cybersecurity6
Healthtech6
Enterprise software2
6 more
Fintech2
Space tech2
Climate tech1
Defense tech1
Developer tools1
Foodtech1

By country

United States31
United Kingdom8
Bulgaria1
France1

Rounds

41 in all activity
Estuary Biotherapeutics

Estuary Biotherapeutics develops locally delivered gene therapies for patients with inherited polycystic kidney disease.

$93MSeries A
Participant
OMass Therapeutics

OMass Therapeutics develops small-molecule medicines for endocrine and immune diseases using a platform that measures drug targets in their biological surroundings.

$310MSeries C
Participant
Allara

Virtual care for women with hormonal, metabolic and reproductive health needs.

$30MFunding
Participant
Armadin

Armadin develops AI agents that test attack paths across enterprise systems and show defenders how connected weaknesses could be exploited.

$255.5MSeries B
Participant
Metaview

Metaview provides AI agents and software for recruiters and hiring teams, from candidate sourcing and screening to interview notes and reporting.

$60MSeries C
Participant
Snorkel AI

Snorkel AI helps enterprises build expert-curated training data and benchmarks for advanced AI models and agents.

$350MSeries E
Participant
EnduroSat

EnduroSat designs and manufactures modular, software-defined satellites and components, and provides mission services for commercial and institutional operators.

$205MFunding round
Participant
Encoded Therapeutics Inc.

Encoded develops precision gene therapies for neurological disorders, led by ETX101, a gene-regulation therapy for people with SCN1A-positive Dravet syndrome.

$275MSeries F
Lead
Blacksmith

Cloud infrastructure for validating and testing AI-generated code faster

$45MSeries B
Role not disclosed
LifeMine Therapeutics

Develops fungal genome-derived therapeutics for organ transplant rejection

$263MSeries D+Series E
Role not disclosed
Obsidian Security

Secures non-human identities and AI agents operating in third-party applications

$85MSeries D
Role not disclosed
Wonder

A leading food technology platform built to make great food more accessible

$650MSeries D
Role not disclosed
Nebex

Builds market infrastructure connecting space companies with sovereign buyers and capital

$30MSeed
Role not disclosed
Odyssey

Builds general-purpose world models that simulate physical reality for robotics, gaming, and autonomous systems

$310MSeries B
Role not disclosed
Contraline

Develops hormonal and non-hormonal male contraceptives for men and couples globally

$92.5MSeries B
Role not disclosed
MokN

Protects organisations from credential theft and identity-based attacks through active identity recovery technology

$15MSeries A
Role not disclosed
Signos, Inc.

Offers an FDA-cleared AI-powered glucose monitoring system for weight management and metabolic health

$20MGrowth
Role not disclosed
Flick

AI-native filmmaking platform giving creators cinematic control to direct AI-generated films

$6MSeed
Role not disclosed
Nectar Social

Provides AI infrastructure for modern marketing

$30MSeries A
Role not disclosed
Recursive Superintelligence

Develops self-improving AI systems that autonomously enhance their own architecture and training algorithms

$650MSeries A
Role not disclosed
Isomorphic Labs

Builds an AI-first drug design engine to accelerate discovery and development across multiple therapeutic areas

$2.1BSeries B
Role not disclosed
Iterative Health

Develops technology and services for clinical research.

$77MSeries C
Role not disclosed
Wealth.com

Provides AI-powered estate and tax planning platform for wealth management firms

$65MSeries B
Role not disclosed
Censys

Provides Internet intelligence and insights for security operations and exposure management

$70MSeries D
Role not disclosed
Sift

Delivers AI data infrastructure for mission-critical machines across space, defense, and autonomy

$42MSeries B
Role not disclosed
Translucent

Provides AI platform for healthcare finance

$27MSeries A
Role not disclosed
Armadin

Armadin develops AI agents that test attack paths across enterprise systems and show defenders how connected weaknesses could be exploited.

$189.9MSeed+Series A
Role not disclosed
SambaNova

Provides next-generation AI infrastructure for enterprises, neo-clouds, and sovereign AI initiatives

$350MSeries E
Role not disclosed
SolveAI

Enables employees to build enterprise-grade apps using natural language with secure IT integration

$45MSeries A
Role not disclosed
Basis

Provides AI agents for accountants to complete complex accounting workflows end-to-end

$100MSeries B
Role not disclosed